
News|Articles|September 2, 2003
- Pharmaceutical Technology-09-02-2003
- Volume 27
- Issue 9
Counterfeiting, Compliance, and Controls
Author(s)Jill Wechsler
FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.
Advertisement
Articles in this issue
almost 23 years ago
September 2003almost 23 years ago
In the Spotlight September 2003almost 23 years ago
September 2003almost 23 years ago
Disposable Filtration Lightens Cleaning and Validation Loadalmost 23 years ago
CROs Hoping for Research Burst in Second Half of 2003almost 23 years ago
Improved Blister Packaging Benefits Consumers, Caregivers, and Drug MakersAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
2
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
3
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
4
Pharma's Next AI Problem Is Authority
5




